| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |